As the high prevalence of LRP1b mutation has been shown in PCa [161] and a correlation between LRP1b mutation and the ICI response has been shown in melanoma patients [162], the authors hypothesized that LRP1b mutations may represent a surrogate marker for the mutational load [120]. The gene discussed is LRP1B; the disease is posterior cortical atrophy.